ArticleThe oncologist2022

Neoadjuvant Dovitinib in Early- and Intermediate-Stage Hepatocellular Carcinoma.

Alessandro Rizzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.